WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 3 fonti

Correction to Celcuity Gets FDA Approval Headline

Celcuity's breast cancer drug received approval from the Food and Drug Administration. "Clecuity Gets FDA Approval for Breast Cancer Drug," at 5:33 p.m. ET, misspelled the company name in the headline.

Raccontata dafiercepharma.commorningstar.combiopharmadive.com

Confronto fonti

3 prospettive sulla stessa storia
AI · summaries
morningstar.comStai leggendo1 g fa

Correction to Celcuity Gets FDA Approval Headline

Celcuity's breast cancer drug received approval from the Food and Drug Administration. "Clecuity Gets FDA Approval for Breast Cancer Drug," at 5:33 p.m. ET, misspelled the company name in the headline.

originale
fiercepharma.com1 g fa

With FDA approval for its breast cancer blockbuster hopeful, Celcuity could ‘belong in the hands’ of a Big…

The FDA has approved a new | The FDA has approved a new small molecule inhibitor from Celcuity with blockbuster potential that could become a new standard-of-care for patients with breast cancer.

Leggi questa versione → originale
biopharmadive.com1 g fa

Celcuity gains FDA approval for closely watched breast cancer drug

Still, shares fell by nearly 20% after the company revealed a delay in the coming launch of Revtorpyk. Details in the drug’s prescribing information surprised some analysts, too.

Leggi questa versione → originale

Timeline cronologica

  1. martedì 14 luglio 2026·fiercepharma.com

    With FDA approval for its breast cancer blockbuster hopeful, Celcuity could ‘belong in the hands’ of a Big Pharma

    The FDA has approved a new | The FDA has approved a new small molecule inhibitor from Celcuity with blockbuster potential that could become a new standard-of-care for patients…

  2. mercoledì 15 luglio 2026·morningstar.com

    Correction to Celcuity Gets FDA Approval Headline

    Celcuity's breast cancer drug received approval from the Food and Drug Administration. "Clecuity Gets FDA Approval for Breast Cancer Drug," at 5:33 p.m. ET, misspelled the company…

  3. mercoledì 15 luglio 2026·biopharmadive.com

    Celcuity gains FDA approval for closely watched breast cancer drug

    Still, shares fell by nearly 20% after the company revealed a delay in the coming launch of Revtorpyk. Details in the drug’s prescribing information surprised some analysts, too.